432 related articles for article (PubMed ID: 12244575)
41. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
Yuan W; Varga J
J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
[TBL] [Abstract][Full Text] [Related]
42. Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter.
Denissova NG; Pouponnot C; Long J; He D; Liu F
Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6397-402. PubMed ID: 10823886
[TBL] [Abstract][Full Text] [Related]
43. The smad proteins and TGFbeta signalling: uncovering a pathway critical in cancer.
Rooke HM; Crosier KE
Pathology; 2001 Feb; 33(1):73-84. PubMed ID: 11280614
[TBL] [Abstract][Full Text] [Related]
44. TGFbeta-inducible early gene (TIEG) also codes for early growth response alpha (EGRalpha): evidence of multiple transcripts from alternate promoters.
Fautsch MP; Vrabel A; Subramaniam M; Hefferen TE; Spelsberg TC; Wieben ED
Genomics; 1998 Aug; 51(3):408-16. PubMed ID: 9721211
[TBL] [Abstract][Full Text] [Related]
45. Characterization of the DNA-binding property of Smad5.
Li W; Chen F; Nagarajan RP; Liu X; Chen Y
Biochem Biophys Res Commun; 2001 Sep; 286(5):1163-9. PubMed ID: 11527422
[TBL] [Abstract][Full Text] [Related]
46. Smad7 is a TGF-beta-inducible attenuator of Smad2/3-mediated inhibition of embryonic lung morphogenesis.
Zhao J; Crowe DL; Castillo C; Wuenschell C; Chai Y; Warburton D
Mech Dev; 2000 May; 93(1-2):71-81. PubMed ID: 10781941
[TBL] [Abstract][Full Text] [Related]
47. Modulation of transforming growth factor beta (TGFbeta)/Smad transcriptional responses through targeted degradation of TGFbeta-inducible early gene-1 by human seven in absentia homologue.
Johnsen SA; Subramaniam M; Monroe DG; Janknecht R; Spelsberg TC
J Biol Chem; 2002 Aug; 277(34):30754-9. PubMed ID: 12072443
[TBL] [Abstract][Full Text] [Related]
48. Tissue, cell type, and breast cancer stage-specific expression of a TGF-beta inducible early transcription factor gene.
Subramaniam M; Hefferan TE; Tau K; Peus D; Pittelkow M; Jalal S; Riggs BL; Roche P; Spelsberg TC
J Cell Biochem; 1998 Feb; 68(2):226-36. PubMed ID: 9443078
[TBL] [Abstract][Full Text] [Related]
49. Genomic locus and promoter region of rat Smad7, an important antagonist of TGFbeta signaling.
Stopa M; Benes V; Ansorge W; Gressner AM; Dooley S
Mamm Genome; 2000 Feb; 11(2):169-76. PubMed ID: 10656934
[TBL] [Abstract][Full Text] [Related]
50. The role of TGFbeta in human cancers.
Wong SF; Lai LC
Pathology; 2001 Feb; 33(1):85-92. PubMed ID: 11280615
[TBL] [Abstract][Full Text] [Related]
51. BRCA2 and Smad3 synergize in regulation of gene transcription.
Preobrazhenska O; Yakymovych M; Kanamoto T; Yakymovych I; Stoika R; Heldin CH; Souchelnytskyi S
Oncogene; 2002 Aug; 21(36):5660-4. PubMed ID: 12165866
[TBL] [Abstract][Full Text] [Related]
52. Identification and expression of HySmad1, a member of the R-Smad family of TGFbeta signal transducers, in the diploblastic metazoan Hydra.
Hobmayer B; Rentzsch F; Holstein TW
Dev Genes Evol; 2001 Dec; 211(12):597-602. PubMed ID: 11819117
[TBL] [Abstract][Full Text] [Related]
53. [Cellular signaling in response to TGFbeta: the paradox of a factor that blocks cell proliferation and enhances metastasis].
Vignais ML
Bull Cancer; 1999 Nov; 86(11):903-10. PubMed ID: 10586106
[TBL] [Abstract][Full Text] [Related]
54. Possible role of TIEG1 as a feedback regulator of myostatin and TGF-beta in myoblasts.
Miyake M; Hayashi S; Iwasaki S; Chao G; Takahashi H; Watanabe K; Ohwada S; Aso H; Yamaguchi T
Biochem Biophys Res Commun; 2010 Mar; 393(4):762-6. PubMed ID: 20171187
[TBL] [Abstract][Full Text] [Related]
55. Expression of the inhibitory Smad7 in early mouse development and upregulation during embryonic vasculogenesis.
Zwijsen A; van Rooijen MA; Goumans MJ; Dewulf N; Bosman EA; ten Dijke P; Mummery CL; Huylebroeck D
Dev Dyn; 2000 Aug; 218(4):663-70. PubMed ID: 10906784
[TBL] [Abstract][Full Text] [Related]
56. [The expression and function of Smad7 during human tooth germ development].
Bao L; Niu Z; Shi J
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Dec; 21(6):438-40. PubMed ID: 14732975
[TBL] [Abstract][Full Text] [Related]
57. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta.
von Gersdorff G; Susztak K; Rezvani F; Bitzer M; Liang D; Böttinger EP
J Biol Chem; 2000 Apr; 275(15):11320-6. PubMed ID: 10753944
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-1R-associated kinase 2 is a novel modulator of the transforming growth factor beta signaling cascade.
Mullenders J; Fabius AW; van Dongen MM; Kuiken HJ; Beijersbergen RL; Bernards R
Mol Cancer Res; 2010 Apr; 8(4):592-603. PubMed ID: 20332216
[TBL] [Abstract][Full Text] [Related]
59. Elevated TGFbeta-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease.
Hassane S; Leonhard WN; van der Wal A; Hawinkels LJ; Lantinga-van Leeuwen IS; ten Dijke P; Breuning MH; de Heer E; Peters DJ
J Pathol; 2010 Sep; 222(1):21-31. PubMed ID: 20549648
[TBL] [Abstract][Full Text] [Related]
60. The Smad transcriptional corepressor TGIF recruits mSin3.
Wotton D; Knoepfler PS; Laherty CD; Eisenman RN; Massagué J
Cell Growth Differ; 2001 Sep; 12(9):457-63. PubMed ID: 11571228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
